Here are the 8-K filings from Aehr Test Systems (AEHR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow AEHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AEHR filings page.
Aehr Test Systems reported first-quarter fiscal 2027 revenue of $33.0 million, up 200% year over year, and GAAP net income of $7.2 million, versus a $2.1 million loss a year earlier. Non-GAAP net income was $9.4 million. Bookings were $46.7 million; backlog was $100.9 million as of September 25, 2026, and effective backlog, including bookings received after quarter end, was $109.3 million as of November 1.
Aehr raised its fiscal 2027 revenue outlook to $150 million from a prior range of $130 million to $150 million and expects non-GAAP net income of at least 20% of revenue. A customer has decided to purchase a fully configured FOX-XP test cell for planned installation at a Taiwan OSAT partner in early calendar 2027. A high-volume production evaluation is planned, with a decision anticipated within several months after installation and validation.
Aehr is shipping and installing more than a dozen Sonoma systems per month for a lead hyperscale customer. Its second AI processor completed qualification and has follow-on orders for initial production sampling, with a production ramp anticipated in calendar 2027. Operating activities used $3.054 million cash, versus $282,000 in the three months ended August 29, 2025.
Aehr Test Systems appointed Narsing Vijayrao to its board, effective October 28, 2026, after increasing the authorized number of directors from six to seven. He joins the Compensation Committee and will serve until the next annual meeting of shareholders. The board determined that he qualifies as an independent director under Nasdaq listing standards.
Upon the effective date, Vijayrao will receive a $65,000 annual cash retainer and an initial RSU grant totaling $140,000, with the number of RSUs based on the stock price on the grant date. The initial grant vests in 1/16 increments on quarterly anniversaries over four years, subject to continued service. He will also be eligible for annual RSU grants totaling $140,000, vesting in 1/4 increments on quarterly anniversaries over one year, subject to continued service.
At AEHR Test Systems’ October 19, 2026 annual meeting, shareholders elected Rhea J. Posedel, Gayn Erickson, Fariba Danesh, Laura Oliphant, Geoffrey G. Scott and Howard T. Slayen as directors. Each will serve until the next annual meeting or until a successor is elected and qualified, subject to earlier departure as described in the company’s terms.
Shareholders ratified BPM LLP as the independent registered public accounting firm for the fiscal year ending June 25, 2027, and approved named executive officer compensation on a non-binding, advisory basis. Of 32,659,546 shares entitled to vote, 22,928,987 were present in person or by proxy.
Aehr Test Systems reported fiscal fourth quarter 2026 net revenue of $18.8 million, up from $14.1 million a year earlier, with GAAP net income of $1.4 million, or $0.04 per diluted share. Non-GAAP net income was $3.6 million, or $0.11 per diluted share. Quarterly bookings reached a record $60.7 million, backlog was $80.6 million, and effective backlog, including post-quarter bookings, was $100.6 million. Total cash, cash equivalents and restricted cash rose to $116.5 million, supported by $97.4 million in net proceeds from a public equity offering.
For fiscal 2026, net revenue was $50.0 million, down from $59.0 million in 2025, with a GAAP net loss of $7.1 million versus a $3.9 million loss previously; non-GAAP net income was $0.9 million. Operations used $3.3 million of cash. Management highlights strong demand across AI processors, silicon photonics and power semiconductors, including approximately $8 million of recent silicon carbide WaferPak orders and growing package-level burn-in for AI. For fiscal 2027, Aehr projects revenue between $130 million and $150 million, representing roughly 160%–200% year-over-year growth, and targets non-GAAP net income of 18%–22% of revenue, supported by its effective backlog of about $100 million and expanding customer programs.
Aehr Test Systems completed sales under its at-the-market equity offering program, generating aggregate gross proceeds of approximately $60.0 million from common stock issuances. The shares were sold under an effective Form S-3 shelf registration that registered up to $100.0 million of securities, using a prospectus supplement dated April 8, 2026.
Aehr Test Systems entered into an equity distribution agreement on April 8, 2026 with William Blair & Company and Craig-Hallum Capital Group to sell up to $60,000,000 of common stock through an at-the-market offering program. Sales will be made from time to time under an effective Form S-3 shelf registration and an April 8, 2026 prospectus supplement. The agents will use commercially reasonable efforts to place shares and will receive a commission of up to 3.0% of gross proceeds. Either the company or the agents can suspend or terminate the program upon written notice.
Aehr Test Systems reported third quarter fiscal 2026 net revenue of $10.3 million, down from $18.3 million a year earlier, as it posted a GAAP net loss of $3.2 million, or $(0.10) per diluted share. Non-GAAP net loss was $1.5 million, or $(0.05) per diluted share. Despite weaker revenue, Aehr booked $37.2 million of orders with a book-to-bill ratio over 3.5x, lifting backlog to $38.7 million, or $50.9 million including post-quarter bookings. Cash, cash equivalents and restricted cash were $37.1 million, up from $31.0 million in late November 2025. Management expects full-year fiscal 2026 revenue to be on the high side of its $45–$50 million outlook and reiterated second-half guidance of $25–$30 million revenue and non-GAAP net loss per share between $(0.09) and $(0.05), citing strong AI and data center demand.
Aehr Test Systems filed a current report to note that it issued a press release on January 8, 2026 announcing its financial results for the fiscal 2026 second quarter ended November 28, 2025. The company also used the release to communicate a reinstatement of its fiscal 2026 guidance. The press release is furnished as Exhibit 99.1 and is not deemed filed for liability purposes under certain securities laws.
Aehr Test Systems reported that stockholders approved amendments to two compensation plans at the company’s 2025 annual stockholders’ meeting held on October 20, 2025. The approvals cover the Amendment to the Amended and Restated 2006 Employee Stock Purchase Plan and the Amendment to the 2023 Equity Incentive Plan.
The company states that the terms of these amendments are set forth in the proxy statement dated September 10, 2025, which is incorporated by reference. The full texts of the amendments were filed as exhibits 10.1 and 10.2. This update was disclosed under Item 5.02 of an 8-K.
Aehr Test Systems reported results of its October 20, 2025 annual meeting. Of 29,968,988 shares entitled to vote, 20,156,704 were represented in person or by proxy.
Shareholders elected six directors. They approved an amendment to the 2023 Equity Incentive Plan to add 2,500,000 shares and an amendment to the Employee Stock Purchase Plan to add 300,000 shares. The selection of BPM LLP as independent registered public accounting firm for the fiscal year ending May 29, 2026 was ratified. A non-binding advisory vote approved executive compensation. On frequency, shareholders supported holding the advisory vote on executive compensation every 1 year, and the Board determined to adopt an annual cadence. The next required advisory vote on frequency will occur no later than the 2031 Annual Meeting.
Aehr Test Systems filed a current report to share that it has released its financial results for the fiscal 2026 first quarter, which ended on August 29, 2025. The company announced these results through a press release dated October 6, 2025.
The report explains that the press release is provided as an exhibit for informational purposes and is not treated as formally filed financial statements. The filing does not detail the actual revenue, earnings, or other performance figures, directing readers instead to the accompanying press release for the full fiscal 2026 first quarter financial results.